Note the close relationship with the CEO of Rockeby (RBY) and the Singapore Government, now this has to be good! Awaiting further deals with the government
Dr Tan Sze Wee (MBBS, MBA) CEO and MD Rockeby Biomed Limited
Dr Tan Sze Wee is the CEO and Managing Director of Rockeby Biomed Limited. He is responsible for the overall management and strategic direction of the Company and the Rockeby Group. Dr Tan joined Rockeby on 1st July 2001 and was also appointed to the Board on 29 October 2003. Prior to joining Rockeby, Dr Tan was the Asia-Pacific Associate Regional Medical Director for Mead Johnson
Nutritionals, a division of Bristol-Myers Squibb Company from 1997 to 2001.
Dr Tan is currently the official spokesperson and council member of the Singapore Medical Association (“SMA”). He has been part of the SMA’s Executive Committee since 1996 and has performed the duties of Assistant Honorary Secretary, Assistant Treasurer and Treasurer during this period of time. He is currently the Chairman of the Singapore Medical Association Private Limited, the commercial entity of SMA. Dr Tan has represented SMA on several Ministry of Health Committees such as the Singapore Medical Council Continuing Medical Education Co-ordinating Committee and the Maintenance of Competence Committee. He also represented SMA as a committee member in the Advertising Standards Authority of Singapore’s Executive Committee since 1999. Dr Tan was awarded the Spirit of Enterprise 2004 award for his success in Entrepreneurship.
Dr Tan was appointed to the Singapore Parliament on January 2005 for a 2½ year term as a Nominated Member of Parliament. Dr Tan graduated with a Bachelor of Medicine and a Bachelor of Surgery (“MBBS”) from the National University of Singapore, and attained his Masters of Business Administration (“MBA”) from Warwick University, UK. He is an affiliate member of the Faculty of Pharmaceutical Medicine, Royal College of Physicians, UK.
RBY Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
